ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Interest Expense
Cost of servicing the company's debt during the period.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Interest Expense · Q1 FY2026 · quarter ended Mar 2026
Interest expense growth accelerates
Q1 FY2026 interest expense of $1.73M rose 1883.9% year over year, ahead of the +567.3% change in trailing-twelve-month interest expense. Sequentially, it rose 565.0% from the prior quarter.
Context
- Interest expense amounted to 2.4% of revenue in FY2025, down 3.8 pp from a year earlier.
- Interest expense increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +1883.9% holds above the trailing-twelve-month pace of +567.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 575K USD
- Year-over-year change
- +122.1%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 575K | +122.1% |
| FY2024 | 2024-12-31 | 258.87K | +118.4% |
| FY2023 | 2023-12-31 | 118.55K | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Interest Expense vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +567.3% is the highest of 10, against a peer median of +19.8%.
- Interest expense amounts to 8.2% of revenue for ASPI, versus a peer median of 3.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$4.76B BRL | -19.7% | +20.5% | 7.1% | |
| LTM Mar 2026 | $200M USD | +19.8% | +14.8% | 6.9% | |
| LTM Mar 2026 | $79.24M USD | +131.5% | +32.9% | 4.1% | |
| LTM Mar 2026 | $69.6M USD | -2.2% | +7.5% | 5.4% | |
| LTM Mar 2026 | $35.17M USD | +42.6% | +19.5% | 2.8% | |
| LTM Mar 2026 | $28.33M USD | -10.9% | +18.9% | 21.2% | |
| LTM Mar 2026 | $22.14M USD | +90.9% | -26.4% | 1.6% | |
| LTM Mar 2026 | $20.11M USD | +32.0% | +34.0% | 0.9% | |
| LTM Mar 2026 | $2.22M USD | +567.3% | — | 8.2% | |
| LTM Apr 2026 | $2.21M USD | -14.9% | +25.6% | 0.5% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ASPI) | — | +19.8% | +19.5% | 3.5% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 433.03K | 4.14M | 23.85M |
| Cost of Revenue | 19.38K | 0 | 294.06K | 2.55M | 20.44M |
| Gross Profit | (19.38K) | 0 | 138.97K | 1.6M | 3.41M |
| Gross Margin | — | — | 32.1% | 38.6% | 14.3% |
| Research & Development | 41.61K | 1.27M | 764.58K | 3.14M | 12.36M |
| Selling, General & Admin | 2.55M | 3.83M | 15.42M | 24.81M | 48.24M |
| Operating Expenses | 2.59M | 5.1M | 16.18M | 27.95M | 60.6M |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471K | 1.91M |
| EBITDA | (2.59M) | (4.87M) | (16.14M) | (31.58M) | (157.07M) |
| EBITDA Margin | — | — | -3728.2% | -762.1% | -658.6% |
| Operating Income | (2.61M) | (5.1M) | (16.04M) | (26.35M) | (57.19M) |
| Operating Margin | — | — | -3704.6% | -636.0% | -239.8% |
| Interest Income | 115 | 3.38K | 9.07K | 1.24M | 6.79M |
| Interest Expense | 0 | 0 | 118.55K | 258.87K | 575K |
| Other Income / Expenses | 113 | 153.91K | (258.26K) | (5.96M) | (102.37M) |
| Income Before Tax | (2.61M) | (4.95M) | (16.3M) | (32.31M) | (159.56M) |
| Pre-Tax Margin | — | — | -3764.3% | -779.7% | -669.0% |
| Income Tax Expense | 0 | 0 | (6.13K) | 111.45K | 282K |
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.33M) | (175.09M) |
| Net Margin | — | — | -3761.0% | -780.3% | -734.2% |
| EPS (Basic) | (0.08) | (0.13) | (0.49) | (0.63) | (2.11) |
| EPS (Diluted) | (0.08) | (0.13) | (0.49) | (0.63) | (2.11) |
| Weighted Avg Shares | 34.36M | 35.91M | 33.07M | 55.67M | 83.01M |
| Weighted Avg Shares (Diluted) | 34.36M | 35.91M | 33.07M | 55.67M | 83.01M |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.